Randomized placebo-and active controlled study of eplivanserin, a novel sleep agent, on next-day psychomotor and cognitive tasks in healthy subjects

被引：0
|
作者：
Micallef-Roll, J.
Roy, C.
Delfolie, A.
Pinquier, J. L.
Blin, O.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
544
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF EPLIVANSERIN, A NON-SEDATIVE AGENT, ON DRIVING AND COGNITIVE/PSYCHOMOTOR PERFORMANCE: A RANDOMIZED PLACEBO- AND ACTIVE-CONTROLLED TRIAL IN INSOMNIA, PATIENTS WITH DIFFICULTIES MAINTAINING SLEEP
    Luthringer, R.
    Floch, A.
    Delfolie, A.
    Nicolas, O.
    Brunet, A.
    Pinquier, J.
    SLEEP, 2009, 32 : A35 - A36
  • [2] Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects
    Mets, Monique A. J.
    de Vries, Juna M.
    Domis, Lieke M. de Senerpont
    Volkerts, Edmund R.
    Olivier, Berend
    Verster, Joris C.
    SLEEP, 2011, 34 (10) : 1327 - 1334
  • [3] Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects
    Boyle, Julia
    Wolford, Dennis
    Gargano, Cynthia
    McCrea, Jacqueline
    Cummings, Corinne
    Cerchio, Kristine
    Lines, Christopher
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (01) : 61 - 71
  • [4] The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo
    O'Neill, WM
    Hanks, GW
    Simson, P
    Fallon, MT
    Jenkins, E
    Wesnes, K
    PAIN, 2000, 85 (1-2) : 209 - 215
  • [5] Next-day driving effects of indiplon and zopiclone: Results of a double-blind, placebo-controlled, crossover study in healthy volunteers
    Farber, R.
    Macher, J.
    Kean, Y.
    SLEEP, 2006, 29 : A44 - A44
  • [6] THE COGNITIVE AND PSYCHOMOTOR EFFECTS OF OPIOID ANALGESICS .1. A RANDOMIZED CONTROLLED TRIAL OF SINGLE DOSES OF DEXTROPROPOXYPHENE, LORAZEPAM AND PLACEBO IN HEALTHY-SUBJECTS
    ONEILL, WM
    HANKS, GW
    WHITE, L
    SIMPSON, P
    WESNES, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 447 - 453
  • [7] THE COGNITIVE AND PSYCHOMOTOR EFFECTS OF OPIOID ANALGESICS .2. A RANDOMIZED CONTROLLED TRIAL OF SINGLE DOSES OF MORPHINE, LORAZEPAM AND PLACEBO IN HEALTHY-SUBJECTS
    HANKS, GW
    ONEILL, WM
    SIMPSON, P
    WESNES, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 455 - 460
  • [8] Concentration-Qt Analysis Of The Randomized, Placebo-And Moxifloxacin-Controlled Thorough Qt Study Of Inhaled Umeclidinium Monotherapy And Inhaled Umeclidinium/vilanterol Combination In Healthy Subjects
    Mehta, R.
    Green, M.
    Patel, B.
    Wagg, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [9] Impact of Escitalopram on Nocturnal Sleep, Day-Time Sleepiness and Performance Compared to Amitriptyline: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects
    Doerr, J. P.
    Spiegelhalder, K.
    Petzold, F.
    Feige, B.
    Hirscher, V.
    Kaufmann, R.
    Riemann, D.
    Voderholzer, U.
    PHARMACOPSYCHIATRY, 2010, 43 (05) : 166 - 173
  • [10] Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial
    Kay, Gary G.
    Schwartz, Howard I.
    Wingertzahn, Mark A.
    Jayawardena, Shyamalie
    Rosenberg, Russell P.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (03) : 217 - 226
12345